BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2009
View Archived Issues
Autoantigen insulin vaccine shows potential in newly diagnosed type 1 diabetes mellitus
Read More
OSU-HDAC42 shows potency in in vivo and in vitro models of bladder cancer
Read More
Amicus suspends enrollment for phase II AT-2220 trial in Pompe disease
Read More
Faes Farma seeks approval for bilastine in 29 European countries
Read More
Abbott scientists describe new anticancer Sp1 inhibitors in recent patent
Read More
FDA issues complete response letter regarding Traclee sNDA
Read More
Novel VEGFR-3 (FLT4) inhibitors prepared and tested at sanofi-aventis
Read More
AstraZeneca claims novel JAK2 inhibitors with potential as anticancer agents
Read More
Nektar reports positive results from phase II oral NKTR-118 study
Read More
Astellas and XenoPort announce results from phase II ASP-8825/XP-13512 trial
Read More
Aerovance initiates phase IIb Aerovant trial for uncontrolled asthma
Read More
Eribulin active in phase II study in castration-resistant prostate cancer patients
Read More
Serlopitant effective but less so than tolterodine in overactive bladder
Read More
AGS-PSCA treatment refined in phase Ib study in prostate cancer
Read More
BioAlliance Pharma reacquires European rights to Loramyc
Read More
Endo licenses axomadol and returns rights to Transdur-sufentanil
Read More
Merck & Co. commences phase II study of oral deforolimus under Ariad collaboration
Read More
FDA approves Pluristem's IND application to initiate phase I clinical trial of PLX-PAD
Read More
Intranasal Therapeutics changes name to Ikano Therapeutics and completes series B financing
Read More
Hi-Tech Pharmacal acquires ECR Pharmaceuticals for USD 5.1 million
Read More
Xencor and Pfizer sign technology licensing agreement for Xtend and XmAb
Read More
Marinus presents successful results from phase II ganaxolone trial
Read More
New EphB4 inhibitors reported in recent AstraZeneca patents
Read More
Auxilium submits BLA for Xiaflex for Dupuytren's contracture
Read More
New Hsp90 inhibitors reported in recent patent from Merck KGaA
Read More